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Abstract
Lectin–glycan interactions play important roles in many biological systems, but the nature of
glycoprotein counter-receptors expressed on cell membranes is often poorly understood. To help
overcome this problem, we developed a method based on proximity labeling technology. Using a
peroxidase-coupled lectin, addition of H2O2 and tyramide-biotin substrates leads to generation of
short-range biotin radicals that biotinylate proteins in the immediate vicinity of the bound lectin,
which can subsequently be identiﬁed. As a proof-of-principle, sialoadhesin-horseradish peroxid-
ase-human IgG1 Fc recombinant protein constructs were precomplexed with anti-Fc antibodies,
bound to human erythrocytes and reacted with H2O2 and tyramide-SS-biotin. The erythrocyte
membrane protein with strongest biotinylation was identiﬁed as glycophorin A, in agreement with
early studies using lectin overlay and reglycosylation approaches. As a further test of the method,
the plant lectin MAL II was conjugated with horseradish peroxidase and used in proximity labeling
of human erythrocytes. Glycophorin A was again selectively labeled, which is consistent with pre-
vious reports that MAL II has high afﬁnity for glycophorin. This method could be applied to other
lectins to identify their membrane counter-receptors.
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Introduction
Membrane and secreted proteins are commonly modiﬁed by hetero-
geneous N- and O-glycosylation. The glycans attached to proteins
can be recognized by lectins, which play important roles in infection,
immune responses, cell migration and activation (Sharon and Lis
2004). The ﬁrst lectin was discovered more than 100 years ago (Lee
and Lee 1995; Sharon and Lis 2004) and a large number of lectins
have since been identiﬁed. Using deﬁned glycans and new technolo-
gies such as glycan arrays (Rillahan and Paulson 2011), we now
have a good understanding of their preferred oligosaccharide
ligands, but less is known about the nature of glycoprotein counter-
receptors which carry these ligands (Crocker and Feizi 1996). As a
result of the requirement for multivalency and higher order cluster-
ing for lectin binding, afﬁnity isolation techniques commonly used
to study protein–protein interactions may not be suitable for study-
ing lectin–glycoprotein interactions. For example, the detergents
required for solubilization of membranes are likely to disrupt the
organization and topography of membrane glycoproteins that could
be critical for lectin recognition. In addition, afﬁnity isolation with
immobilized lectins could select artiﬁcially for glycoproteins through
avidity effects or lead to interactions with intracellular glycoproteins
that are not normally found at the cell surface. To circumvent these
issues, it would be desirable to identify lectin counter-receptors at
the cell surface of intact living cells.
Proximity labeling technologies have been used recently to inves-
tigate protein–protein interactions in intact cells (Rees et al. 2015a).
In this technique, an enzyme such as a promiscuous form of a biotin
ligase, BirA* (Roux et al. 2012) or a plant peroxidase (Li et al.
2014) is conjugated to a bait protein. When the bait binds to its tar-
get protein in the presence of enzyme substrates, these are converted
into reactive species, which are only stable over short ranges, leading
to labeling of proteins in the vicinity of the bait. The tagged proteins
can then be enriched by afﬁnity chromatography and identiﬁed by
mass spectrometry or other suitable techniques. These proximity
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labeling technologies provide possible ways to identify lectin
counter-receptors on intact cell membranes of living cells. For sol-
uble lectins which usually exist as oligomeric complexes, such as the
collectins or those isolated from plants, direct conjugation of the lec-
tins with BirA* or peroxidase could be used to identify lectin
counter-receptors. For membrane lectins, conversion to a soluble
form such as the commonly used IgG Fc chimeras, followed by com-
plex formation with anti-IgG Fc polyclonal antibody allows meas-
urement of their interactions with glycan ligands at the cell surface
(Redelinghuys et al. 2011; Kidder et al. 2013; Naito-Matsui et al.
2014). As a result, in vitro complexes of lectin-peroxidase-Fc or lec-
tin-BirA*-Fc fusion proteins could be generated for proximity label-
ing using polyclonal anti-IgG Fc.
In this study, we developed a proximity labeling method to iden-
tify counter-receptors on cell membranes for both membrane and
soluble lectins based on horseradish peroxidase (HRP)-catalyzed
biotinylation. This proximity labeling method utilizes tyramide-SS-
biotin as an HRP substrate, which turns into short lived tyrosyl radi-
cals that can couple to tyrosine residues on proximal proteins (Rees
et al. 2015b). As a model system, we used human erythrocytes
which are heavily sialylated and are recognized by various soluble
and membrane-bound lectins. Sialoadhesin (Sn, Siglec-1, CD169)
was selected as an example of a monomeric membrane lectin since it
has been well characterized in our laboratory in erythrocyte binding
studies. MAL II was selected as an example of a soluble lectin as it
is commercially available as a biotin conjugate that can be readily
coupled to streptavidin-HRP for proximity labeling experiments.
Results
Proximity labeling of erythrocyte glycoproteins using
Sn chimeric proteins
For the initial proximity labeling experiments, Sn-horseradish perox-
idase-human IgG1 Fc (Sn-HRP-Fc) chimeras were produced using a
baculovirus expression system (Supplementary Figure S1). In order
to determine if a linker region between Sn and HRP is required to
provide ﬂexibility for Sn to bind and for HRP to label Sn counter-
receptors efﬁciently, we generated two types of Sn-HRP-Fc chimera
named Sn3L and Sn0L (Supplementary Figure S1). Sn3L has 3
GSGGGGSGGG linkers and surrounding sequences, with a total
length up to ~17 nm between Sn and HRP (calculated on the basis
that the maximum linear dimension of a polypeptide with n residues
is n × 3.6 Angstroms) (Oesterhelt et al. 2000), whereas Sn0L lacks
linkers. For the preparation of multimers, each chimera concentra-
tion was kept constant, with addition of different amount of goat
anti-human IgG Fc to prepare immune-complexes at ratios of 3:1,
1:1 and 0.3:1 anti-Fc:Sn chimera, respectively. Flow cytometry ana-
lysis revealed that the binding of precomplexed Sn-HRP-Fc chimeras
was not greatly affected by the presence of linkers, as both the Sn0L
and Sn3L demonstrated similar binding proﬁles to erythrocytes
(Figure 1A, B), with the strongest binding observed at the 1:1 and
3:1 ratios of FITC-anti-Fc:Sn-HRP-Fc (Figure 1A, B). As expected,
the negative control protein, SnR97A3L, showed no binding activity
at all ratios tested (Figure 1A, B).
In the proximity labeling experiments, strong biotin labeling of a
40 kDa band was observed at the 1:1 and 3:1 ratios of anti-Fc:Sn-
HRP-Fc that was not seen with the SnR97A3L control protein
(Figure 1C). Further evidence for speciﬁc labeling of the 40 kDa
band was seen using α-methyl-NeuAc as a competitive inhibitor of
Sn binding and biotinylation of erythrocytes (Supplementary
Figure S2).
Previous studies indicated that Sn binds to glycophorin on
human erythrocytes (Crocker et al. 1991). Glycophorin A is the
major glycophorin on erythrocytes and the monomeric form has an
apparent molecular mass close to 40 kDa (Chasis and Mohandas
1992). We therefore veriﬁed if this biotinylated 40 kDa band corre-
sponds to glycophorin A. Western blotting for glycophorin A using
total erythrocyte lysates and streptavidin pulldowns of proximity-
labeled material demonstrated that the 40 kDa band corresponded
to monomeric glycophorin A (Figure 1D, F). A dimeric form of gly-
cophorin A at ~80 kDa (Engelman et al. 1992) was also labeled by
Sn-HRP-Fc proteins, most prominently at the 0.3:1 ratios of anti-Fc:
Sn-HRP-Fc (Figure 1C). Higher molecular weight material above
140 kDa was also labeled (Figure 1C, F). This probably corresponds
to biotinylated anti-Fc antibody and/or glycophorin A complexes
resulting from the HRP catalyzed generation of di-tyrosine bonds,
leading to intermolecular crosslinking (Minamihata et al. 2011).
When the pattern of biotinylation in proximity labeling was com-
pared with biotinylation of total membrane proteins using sulfo-
NHS-biotin (Figure 1E), clear differences were seen, providing
strong evidence that the proximity labeling leads to selective biotiny-
lation of glycophorin A.
Given that many lectins are available as Fc-fusion proteins, we
asked whether similar labeling patterns could be obtained using Sn-Fc
protein complexed with HRP-conjugated anti-human Fc antibody.
The 40 kDa band was strongly biotinylated but was absent from the
SnR97A-Fc protein used under the same conditions (Supplementary
Figure S3). These results indicate that very close proximity of HRP to
the lectin binding site may not be crucial for successful proximity
labeling of cell membranes. As an alternative strategy for proximity
labeling that might more closely mimic cell-cell interactions, the Sn
chimeras were immobilized on magnetic beads and then mixed with
erythrocytes. Proximity labeling data revealed that the 40 kDa band
was again preferentially biotinylated, using both Sn-HRP-Fc and Sn-
Fc constructs (Supplementary Figure S4).
Proximity labeling of erythrocyte glycoproteins using
MAL II lectin
MAL II is known to bind human erythrocytes and has a similar ligand
binding preference to Sn, recognizing α2,3-linked sialic acids
(Kawaguchi et al. 1974). The proximity labeling strategy was used to
identify MAL II counter-receptors on erythrocytes. The cells were ﬁrst
incubated with biotinylated MAL II followed by streptavidin-HRP.
The 40 kDa band corresponding to glycophorin A was biotinylated,
but was not seen in control labeling experiments where the erythro-
cytes were mixed with either streptavidin-HRP or with biotinylated
MAL II alone (Figure 2A). Pulldowns of proximity-labeled proteins
demonstrated that the 40 kDa band corresponded to monomeric gly-
cophorin A (Figure 2B). In the MAL II alone control, we saw strong
biotinylated bands at 30 and 60kDa (Figure 2A), which reﬂected the
presence of the biotinylated MAL II. However, these two bands were
not detected when streptavidin-HRP was present. Instead, proteins in
the high molecular weight range (above 140 kDa) were observed,
which could be due to HRP-induced crosslinking of MAL II-
streptavidin-HRP complexes. Overall, the results showed speciﬁc label-
ing of glycophorin A by HRP-conjugated MAL II, which is consistent
with previous reports that glycophorin A has a high afﬁnity for MAL
II (Konami et al. 1994; Geisler and Jarvis 2011).
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Discussion
Proximity labeling has been successfully applied in a growing number
of studies to investigate protein–protein interactions (Roux et al.
2012; Li et al. 2014; Dingar et al. 2015; Rees et al. 2015b). However,
applying proximity labeling to identify lectin counter-receptors is
uniquely challenging due to the weak nature of the lectin–glycan
interaction. In this study, we attempted to address the challenge and
developed a method for lectin counter-receptor identiﬁcations on ery-
throcytes. Erythrocytes are easy to prepare and have been used for
many years in hemagglutination assays to measure lectin binding
activity (Sharon and Lis 2004). In the case of Sn and other Siglecs,
human erythrocytes have been used extensively in a wide range of
assays, as they carry high levels of NeuAc in both α2,3 and α2,6 lin-
kages and can be experimentally modiﬁed to present speciﬁc homo-
genous sialic acid linkages, either through enzymatic reactions or
ganglioside incorporation (Crocker et al. 1991; Kelm et al. 1994).
We veriﬁed our proximity labeling method by demonstrating
that glycophorin A is a predominant counter-receptor for Sn and
MAL II on human erythrocytes. Glycophorin A is a major glycopro-
tein of human erythrocytes and presents O-linked glycans terminat-
ing in α2,3-linked Neu5Ac, preferred glycan ligands for Sn and
MAL II (Crocker et al. 1991; Geisler and Jarvis 2011). Our results
are consistent with previous studies that implicated glycophorin A
as a human erythrocyte counter-receptor for Sn and MAL II
(Crocker et al. 1991; Konami et al. 1994; Geisler and Jarvis 2011).
This method could be applied to identify unknown lectin membrane
counter-receptors on other cells. In that case, the biotinylated pro-
teins could be pulled down by streptavidin beads and the counter-
receptors identiﬁed by quantitative proteomics, as has been well-
documented in studies investigating protein–protein interactions by
proximity labeling (Rees et al. 2015a; Kim and Roux 2016).
A promiscuous form of a biotin ligase, BirA*, is another enzyme
commonly used for proximity labeling (Roux et al. 2012). By releas-
ing activated biotin species, it labels lysine and arginine residues,
which are more commonly found in proteins than tyrosine residues.
In our initial experiments, we generated Sn-BirA*-Fc fusion proteins
with 3 linkers and 0 linkers to develop a complementary proximity
Fig. 1. The binding and biotinylation activities of Sn-HRP-Fc chimeras. Sn3L and Sn0L denotes there are 3 and 0 linkers (GSGGGGSGGG) between the Sn and
HRP respectively. SnR97A3L has a R97A mutation in Sn of the Sn3L chimera and was used as a negative control. For the binding assay, the concentration of
each chimera was kept constant at 2.5 μg/mL, with addition of 7.5, 2.5 and 0.8 μg/mL FITC-conjugated goat anti-human IgG Fc to prepare immune-complexes at
ratios of 3:1, 1:1 and 0.3:1 anti-Fc:Sn chimera, respectively, which are shown after the names of Sn chimeras in the ﬁgure. The binding to human erythrocytes
was analyzed by ﬂow cytometry. For the biotinylation assay, the concentration of each chimera was kept constant at 10 μg/mL, and complexes at ratios of 3:1,
1:1 and 0.3:1 anti-Fc-FITC:Sn-HRP-Fc chimera were prepared, which are shown after the names of Sn chimeras in the ﬁgure. (A) Binding of Sn3L to erythrocytes.
(B) Binding of Sn0L to erythrocytes. (C) Biotinylation of erythrocytes by Sn chimeras. Cells were lysed and blotted with streptavidin-HRP. (D) Erythrocyte lysate
blotted with anti-glycophorin A. (E) Total erythrocyte surface proteins labeled using sulfo-NHS-SS-biotin and the cell lysate was blotted by streptavidin-HRP. (F)
Proteins biotinylated using Sn-HRP-Fc chimeras were pulled down with streptavidin magnetic beads, eluted by reducing LDS sample buffer and blotted with
anti-glycophorin A. This ﬁgure is available in black and white in print and in color at Glycobiology online.
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labeling system. Although the enzyme was active and both chimeras
showed strong binding to erythrocytes, we failed to detect biotinyla-
tion of membrane proteins (unpublished observations), probably
due to the shorter range of BirA*-activated biotin species compared
to HRP-generated products (Rees et al. 2015b).
Overall, the proximity labeling method developed here has the
potential to be applied to many other soluble and membrane-bound
lectins in order to identify their membrane counter-receptors. This
approach could provide new insights into the molecular targets and
biological functions of lectins, including those expressed in the
immune system and involved in cellular and pathogen interactions
and those expressed by microorganisms and important in pathogen-
icity and host invasion.
Materials and methods
Materials
Sn-HRP-Fc DNA constructs were synthesized by GenScript
(GenScript HK Limited). The Sn-Fc chimeras (Crocker et al. 1999)
and Sf9 cells were from laboratory stocks. Sf-900 II serum free
medium, FetalClone II serum, Dynabeads® MyOne™ Streptavidin
C1 magnetic beads, sulfo-NHS-SS-biotin, NuPAGE® sodium dode-
cyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) gels,
MOPS running buffer, LDS sample buffer, sample reducing agent,
and biotinylated goat anti-human IgG Fc were from Thermo Fisher
Scientiﬁc (Paisley, UK). Tyramine hydrochloride, hemin, protein A-
Sepharose®4B, FITC-conjugated goat anti-human IgG Fc, HRP-
conjugated rabbit anti-mouse IgG and HRP-conjugated streptavidin
were from Sigma (Dorset, UK). HRP-conjugated goat anti-human
IgG Fc was from Abcam (Cambridge, UK). Mouse anti-human gly-
cophorin A (Clone: BRIC 163) was from IBGRL Research Products
(Bristol, UK). Biotinylated MAL II was from Vector Laboratories
(Peterborough, UK). Complete™, Mini, EDTA-free protease inhibi-
tor cocktail was from Roche (Boehringer, UK). Human erythrocytes
were collected from volunteer donors under human subject proto-
cols approved by the local ethics committee at the University of
Dundee.
Designing, expression and puriﬁcation of Sn-HRP-Fc
chimeras
The ﬁrst 3 N-terminal Ig-like domains of Sn were selected for con-
struct design. The Sn signal peptide was substituted by honey bee
melittin signal peptide to enhance protein secretion. The DNA cod-
ing the honey bee melittin signal peptide, Sn, 3 GSGGGGSGGG lin-
kers, HRP, and IgG Fc was cloned into pFastBac™1 as shown in
Supplementary Figure S5. Further endonuclease restriction sites
were added to make the construct versatile (Supplementary
Figure S5). Sn in the construct can be changed for another lectin by
cloning using RsrII and EcoRI sites, HRP can be replaced by a pro-
miscuous form of the biotin ligase BirA* through PﬂMI sites, and
the number of linkers can be changed using KpnI, SacI or SalI sites.
L234A L235A mutations were introduced to IgG Fc to reduce its
binding to Fc receptors (Radaev et al. 2001). R97A mutation was
introduced to Sn as a negative control. Sn3L, SnR97A3L and Sn0L
were expressed by Sf9 cells grown in Sf-900 II serum free medium,
according to the instructions of Bac-to-Bac® Baculovirus Expression
System (Thermo Fisher Scientiﬁc). Hemin was added to the cell cul-
ture to a ﬁnal concentration of 0.09 μM to increase the HRP activity
of the chimeras (Segura et al. 2005). The proteins were puriﬁed by
Protein A-Sepharose® 4B and the purity was checked by SDS-PAGE.
Flow cytometry analysis
About 2 × 106 erythrocytes were suspended in 100 μL phosphate-
buffered saline (PBS) containing 1% FetalClone II serum, 2.5 μg/mL
Sn3L or Sn0L chimera, and varying concentrations of FITC-
conjugated goat anti-human IgG Fc at 7.5, 2.5 and 0.8 μg/mL to
prepare immune-complexes with the ratios of 3:1, 1:1 and 0.3:1 of
anti-Fc to Sn chimera, respectively. After 1 h incubation on ice, the
nonbound immune-complexes were washed out by centrifugation
and the cells were re-suspended in 1mL PBS containing 1%
FetalClone II serum for ﬂow cytometry analysis. SnR97A3L was
used as a negative control. The data were analyzed by FlowJo.
Proximity labeling of erythrocyte glycoproteins using
complexes of Sn chimeric proteins in solution
For Sn3L- and Sn0L-guided proximity labeling, 7 × 106 human ery-
throcytes were suspended in 144 μL PBS containing 1% FetalClone
II serum, 10 μg/mL Sn chimera and varying concentrations of FITC-
conjugated goat anti-human IgG Fc at 30, 10 and 3.3 μg/mL to pre-
pare immune-complexes with the ratios of 3:1, 1:1 and 0.3:1 of
anti-Fc to Sn chimera, respectively. The cells were incubated on ice
for 50min then at room temperature for 10min. 1.5 μl 12mM
tyramide-SS-biotin in dimethylformamide, synthesized according to
a previous report (Hopman et al. 1998), and 15 μL 0.3% H2O2
solution in PBS were added and incubated at room temperature for
5min. A 1mL ice-cold quenching buffer (1% FetalClone II serum,
100 U/mL catalase in PBS) was added and the cells were washed
twice with quenching buffer and once with ice-cold PBS containing
1% FetalClone II serum. SnR97A3L was used as a negative control
following the same protocol. For Sn-Fc-chimera-guided proximity
Fig. 2. Biotinylation of human erythrocytes by HRP-conjugated MAL II lectin.
(A) Erythrocytes were incubated with biotinylated MAL II followed by
streptavidin-HRP. Erythrocytes mixed with the same amount of streptavidin-
HRP only were used as a negative control. Erythrocytes incubated with MAL
II only were used as an additional control to conﬁrm the 40 kDa band was not
from biotinylated MAL II. Biotinylated proteins were blotted with Streptavidin-
HRP. (B) Biotinylated proteins were pulled down by streptavidin magnetic
beads, eluted by LDS sample buffer with reducing reagent, and blotted with
anti-glycophorin A.
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biotinylation, the same method was used, except that 10 μg/mL
Sn-Fc and 10 μg/mL HRP-conjugated anti-Fc were mixed to prepare
Sn-Fc-anti-Fc-HRP complexes prior to addition of substrates.
Proximity labeling of erythrocyte glycoproteins using
Sn chimeras immobilized on beads
For Sn-HRP-Fc chimeras, 1 μg biotinylated anti-Fc protein was
mixed with 10 μL streptavidin magnetic beads and incubated at 4°C
overnight. The beads were then washed with PBS containing 1%
FetalClone II serum and incubated with 1 μg Sn3L or Sn0L protein
at 4°C for 2 h. Unbound Sn chimera was washed out with PBS con-
taining 1% FetalClone II serum. For Sn-Fc chimeras, 1 ug Sn-Fc was
mixed with 1 ug HRP-anti-Fc in 100 μL PBS containing 1%
FetalClone II serum, incubated on ice for 30min, then mixed at 4°C
for 2 h with 10 μL magnetic beads which were pre-coated with bioti-
nylated goat anti-human Fc. Unbound was washed out with PBS
containing 1% FetalClone II serum. The beads were incubated on
ice for 50min with 6 × 106 erythrocytes in 90 μl PBS containing 1%
FetalClone II serum, then at room temperature for 10min. For bioti-
nylation, 2 μL tyramide-SS-biotin and 10 μL 0.3% H2O2 in PBS
were added and incubated at room temperature for 5 min. The reac-
tion was quenched as described previously.
Biotinylation of erythrocyte proteins using MAL II lectin
and sulfo-NHS-SS-biotin
For biotinylation of human erythrocytes using MAL II, 3 × 106 ery-
throcytes were incubated on ice for 1 h with 66 μL PBS containing
2.5 μg/mL biotinylated MAL II and 1% FetalClone II serum. After
washing out the nonbound MAL II with 1% FetalClone II serum in
PBS, the cells were resuspended in 66 μL streptavidin-HRP at 5 μg/mL,
1% FetalClone II serum in PBS, incubated on ice for 30min, then at
room temperature for 10min. A 1.5 μL tyramide-SS-biotin and 7 μL
0.3% H2O2 solution were added and incubated at room temperature
for 5min. The reaction was quenched as described previously.
Erythrocytes mixed with the same concentrations of either
streptavidin-HRP or MAL II alone were used as negative controls. For
the biotinylation of total surface proteins on erythrocytes, 3 × 106 PBS
washed erythrocytes were mixed with 80 μL cold PBS adjusted to
pH 8.0 and 20 μL 10mM sulfo-NHS-SS-biotin in PBS pH 8.0 and
incubated at 4°C for 30min. The reaction was terminated by wash-
ing the cells three times using ice-cold TBS.
Western blotting
Erythrocytes were lysed in 20mM Tris–HCl, 5 mM EDTA, 150mM
NaCl, 1% (v/v) Triton X-100, 0.1M sodium thiocyanate, pH 8.0
supplemented with protease inhibitor cocktail. A 20 μL lysis buffer
was added per 106 cells. The cell lysates were loaded to 4–12% Bis–
Tris gel. Each lane corresponds to 4 × 105 erythrocytes. The pro-
teins were separated by SDS-PAGE using MOPS running buffer.
Proteins were transferred to PVDF membranes for western blotting
using streptavidin-HRP for the detection of biotinylated proteins.
Glycophorin A was detected on western blots using mouse anti-
human glycophorin A followed by rabbit anti-mouse IgG-HRP.
Streptavidin pulldowns of biotinylated proteins
A 25 μL streptavidin-HRP dynabeads were washed using PBS, mixed
with 30 μL lysate and 70 μL cell lysis buffer, and incubated at 4°C
overnight. The beads were then washed sequentially according to a
previous report (Rees et al. 2015b) in wash buffer 1 (10mM Tris–Cl,
1% (v/v) Triton X-100, 1mM EDTA, 0.5% (w/v) SDS, 500mM
NaCl, 0.1M sodium thiocyanate, pH 7.4), wash buffer 2 (10mM
Tris–Cl, 1% (v/v) Triton X-100, 1mM EDTA, 0.5% (w/v) SDS,
0.1M sodium thiocyanate, pH 7.4) and PBS at room temperature for
10 min each. The bound proteins were eluted by incubating with 1 ×
LDS reducing sample buffer at room temperature for 10min. The
eluted proteins were analyzed by western blotting. Each lane corre-
sponds to 4 × 105 erythrocytes.
Supplementary data
Supplementary data is available at Glycobiology online.
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